Ratings by Craig-Hallum (Matt Hewitt)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2026 | MaxCyte Inc. | MXCT | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2026 | Lifecore Biomedical | LFCR | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2025 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2025 | Dyadic International | DYAI | New Coverage | Buy (N/A) |
0.91 (0.72) |
-20.88% | Details | |
| 8/6/2025 | Clover Health | CLOV | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2025 | BioHarvest Sciences | BHST | New Coverage | Buy (N/A) |
6.53 (3.20) |
-51% | Details | |
| 2/10/2025 | Alpha Teknova Inc. | TKNO | New Coverage | Buy (N/A) |
9.01 (4.38) |
-51.39% | Details | |
| 12/17/2024 | Clover Health | CLOV | New Coverage | Buy (N/A) |
3.12 (4.70) |
50.64% | Details | |
| 11/22/2024 | Lifecore Biomedical | LFCR | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2024 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2024 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2024 | Neogenomics | NEO | New Coverage | Buy (N/A) |
13.92 (11.17) |
-19.76% | Details | |
| 1/29/2024 | Science 37 | SNCE | Downgrade | Hold (Buy) |
4.74 (5.75) |
21.31% | Details | |
| 1/19/2024 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2024 | Agiliti Inc | AGTI | New Coverage | Buy (N/A) |
7.37 (10.05) |
36.36% | Details | |
| 11/29/2023 | MaxCyte Inc. | MXCT | New Coverage | Buy (N/A) |
4.68 (1.10) |
-76.5% | Details | |
| 11/10/2023 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2023 | BioLife Solutions | BLFS | New Coverage | Buy (N/A) |
21.29 (26.79) |
25.83% | Details | |
| 4/13/2023 | OmniAb, Inc. | OABI | New Coverage | Buy (N/A) |
3.81 (2.33) |
-38.85% | Details | |
| 11/4/2022 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2022 | CynergisTek | CTEK | Downgrade | Hold (Buy) |
0.59 (1.25) |
111.86% | Details | |
| 5/17/2022 | CynergisTek | CTEK | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2021 | Schrodinger | SDGR | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2021 | Surgalign Holdings Inc | SRGA | Downgrade | Hold (Buy) |
1.23 (0.18) |
-85.37% | Details | |
| 8/9/2021 | Surgalign Holdings Inc | SRGA | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2021 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2021 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2021 | Recro Pharma | REPH | New Coverage | Buy (N/A) |
2.85 (2.09) |
-26.67% | Details | |
| 10/28/2020 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2020 | CynergisTek | CTEK | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2020 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2019 | AngioDynamics | ANGO | Maintain | Hold (N/A) |
|
Details | ||
| 8/15/2019 | CynergisTek | CTEK | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2019 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2019 | Omnicell | OMCL | Upgrade | Buy (Hold) |
70.67 (37.93) |
-46.33% | Details | |
| 4/26/2019 | Omnicell | OMCL | Downgrade | Hold (Buy) |
77.45 (70.67) |
-8.75% | Details | |
| 9/17/2018 | Omnicell | OMCL | Maintain | Buy (Buy) |
|
Details |
